Gestationatdiabetes
GDMcomplicatesupto12ofpreanancies.tisdiaqnosed accordinqtotheADPSG{nternationat
AssociationofDiabetesandPreanancv Studv Grouos)orwHO criteria.tis associated withincreased
maternatandfoetaLmorbidity and mortalty.thesemorbiditiescanbeimproved wthoptimisationofaucose
levels andqestationatweiaht aain.Screeninqfor GDM
usually between 24and 2gBweeks;howvever.
shouldbecarriedoutearlierfthere
ahiahriskofGDM.TheHyperqlycemiaand AdversePregnancy
Outcome(HAPO) studyestablishedarelationship betwveen maternauhypergtycaemia and adverse outcomes
andaone-stepapproachtoestablishinqthediaanosisofGDMusinqa75q.2horaualucosetolerancetest
(OGTT)was proposed.
GestationaldiabetesGDMcompuicatesuotol2%ofpreanancies.tisdiaanosedaccordinatothelADPSG
(InternationauAssociationofDiabetes andPreanancv Study Groups) orwHOcriteria.tisassociated with
increased maternatandfoetaL morbidity and mortality;thesemorbiditiescan be improved withoptimisatiomn of
auucoselevelsandaestationauweiaht aain.ScreeninqforGDMisusually between 24 and 2gweeks; however
should becarried out earlierfthereisahiohriskofGDM.Theyperglycemiaand AdversePregnancy
Outcome(HAPO) study established arelationship between maternaLhyperglycaemia and adverse outcomes
andaone-stepapproachtoestablishinqthediaanossofGDMusinaa75a.2horataucosetolerancetest
(OGTT)wasproposed.
@1MINNDOCRINE
